WHO ICTRP trial
Efficacy of addition of hrHPV testing by Hybrid Capture II to conventional…
NL-OMON26473 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON26473 |
|---|---|
| Public title | Efficacy of addition of hrHPV testing by Hybrid Capture II to conventional cytological screening for cervical cancer. |
| Scientific title | Efficacy of addition of hrHPV testing by Hybrid Capture II to conventional cytological screening for cervical cancer. |
| Primary sponsor | - Department of Pathology, VU University Medical Center, Amsterdam - SALTRO Artsenlaboratorium & Trombosedienst, Utrecht |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Conditions | Cervical intraepithelial neoplasia and cervical cancer. Due to the low prevalence of invasive cervical cancer in the Netherlands, and the aim of cervical screening to prevent the occurrence of and death caused by to cervical cancer, we… |
| Interventions | In the VUSABOB, the addition of a high-risk human papillomavirus (hrHPV) test, using the commercially available and FDA approved Hybrid Capture II test, to the regular cervical screening programme in order to improve detection of precursor… |
| Registration date | Sep 5, 2005 |
| Target size | 25000 |
| Secondary IDs | NL178;NTR215; : 2002/02WBO;ISRCTN64621295 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: